Pyxis Oncology Inc
(NAS:PYXS)
$
3.65
-0.11 (-2.93%)
Market Cap: 214.94 Mil
Enterprise Value: 85.17 Mil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 21/100 Pyxis Oncology Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 09:40PM GMT
Release Date Price:
$2.12
(-1.85%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
So welcome back, everybody to the Bank of America Healthcare Conference Day 2. I am Tazeen Ahmad, I'm one of the Senior Biotech Analysts here at the Bank. It is my pleasure to have our next presenting company here with us, Pyxis Oncology. Sitting next to me is Lara Sullivan, who's Chief Executive Officer. Lara, will give a quick overview of the company, kind of, its history and where you are now. And then, we can probably just go into some more detailed Q&A, if that works for you?
Lara S. Sullivan
Pyxis Oncology, Inc. - CEO, President & Director
Sounds great.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Good.
Lara S. Sullivan
Pyxis Oncology, Inc. - CEO, President & Director
Terrific. Thank you. Thank you for having us here today. Pyxis Oncology is a diversified multi-asset multi-modality oncology company. We
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot